Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Denali Therapeutics (DNLI) Other Operating Expenses (2024)

Historic Other Operating Expenses for Denali Therapeutics (DNLI) over the last 1 years, with Q1 2024 value amounting to $14.5 million.

  • Denali Therapeutics' Other Operating Expenses changed N/A to $14.5 million in Q1 2024 from the same period last year, while for Dec 2024 it was $14.5 million, marking a year-over-year change of. This contributed to the annual value of $14.5 million for FY2024, which is N/A changed from last year.
  • As of Q1 2024, Denali Therapeutics' Other Operating Expenses stood at $14.5 million.
  • Over the past 5 years, Denali Therapeutics' Other Operating Expenses peaked at $14.5 million during Q1 2024, and registered a low of $14.5 million during Q1 2024.